Saliva MicroRNA-Based Diagnosis of Children With Autism

A panel of 14 miRNA biomarkers in saliva that are 91% accurate in diagnosing autism in children aged 4-13 (both the false positive and false negative rates are less than 10%). Analysis of the saliva sample can be done using next generation sequencing or qPCR.  Because the current gold standard autism spectrum disorder diagnostic is a questionaire which cannot be administered before a child is 18 to 24 months old, Upstate's new diagnostic holds the promise of allowing accurate testing of infants.

Patent Information:
Technology/Start-up ID: